title: Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes.
abstract: A novel family of vanadyl ion (VO2+, oxidation state +4) carriers is introduced. These carriers possess C2 symmetry, utilize two hydroxamate groups as ion binding sites, and optionally possess asymmetric carbons. Binding efficiencies and hydrophobicities are regulated by the use of a modular assembly. When applied to rat adipocytes, these carriers augment the potency of vanadyl ions to stimulate glucose metabolism. The complexes shift the dose-response curve to the left. Also, the maximal effect of vanadyl ions which is in the order of 20-30% of that of insulin is shifted toward maximal (100-115%) stimulation. Among several chelators studied, the order of synergistic potency was RL-252 greater than or equal to RL-262 greater than 1367. RL-239, RL-280, and RL-261 had smaller effects, whereas RL-282 had a negligible effect. The synergistic action of RL-252 (and other chelators as well) on VO2+ was already observed at a molar ratio of 1:0.01 of VO2+ to RL-252, respectively, and maximal augmentation occurred at a molar ratio of 1:0.1. The superiority of the hydrophobic chelators relative to the hydrophilic ones, together with the low molar ratio of chelator to VO2+ to achieve maximal effect, strongly suggests that these chelators act as vanadyl ionophores. This notion was confirmed by carrier-facilitated extraction of VO2+ from water into CHCl3 with the following order of decreasing efficacy: RL-262 greater than RL-252 greater than 1367 greater than RL-261. The chelators' potentiating effect may therefore be related to facilitated transport of VO2+ ions into the cells' interiors.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Hormone Research Weizmann Institute of Science, Rehovot Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Shechter
authors.forename: A
authors.initials: A
authors.lastname: Shisheva
authors.forename: R
authors.initials: R
authors.lastname: Lazar
authors.forename: J
authors.initials: J
authors.lastname: Libman
authors.forename: A
authors.initials: A
authors.lastname: Shanzer
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D002614:Chelating Agents; D004357:Drug Synergism; D005947:Glucose / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014638:Vanadates / Q000378:metabolism*
chemical_list: D002614:Chelating Agents; D008055:Lipids; D014638:Vanadates; D005947:Glucose